|
Mortality and relative risk of MI in the venous thromboembolism cohort compared with the control cohort, according to year of follow up. |
||||||
| First year |
After 1 year |
|||||
|
|
||||||
| Deaths (n = 1216) |
Mortality/1000 person-years (95% CI) |
RR (95% CI)a |
Deaths (n = 1872) |
Mortality/1000 person-years (95% CI) |
RR (95% CI)a |
|
|
|
||||||
| Control cohort |
716 |
16.0 (14.9–17.1) |
1 |
1550 |
13.9 (13.2–14.6) |
1 |
| All VTE cases |
500 |
97.8 (89.6–106.8) |
3.8 (3.4–4.3) |
322 |
28.1 (25.2–31.3) |
1.6 (1.4–1.8) |
| DVT |
344 |
113.4 (102.0–126.1) |
4.4 (3.9–5.1) |
186 |
27.7 (24.0–32.0) |
1.6 (1.4–1.9) |
| PE |
156 |
75.1 (64.2–87.9) |
2.9 (2.5–3.5) |
136 |
28.7 (24.2–33.9) |
1.6 (1.3–1.9) |
|
CI, confidence interval; DVT, deep vein thrombosis; PE, pulmonary embolism; RR, relative risk; VTE, venous thromboembolism. aRelative risk estimated by Cox regression adjusted for age, sex, calendar year, consultations in the previous year, cancer, heart failure and ischaemic heart disease. | ||||||
Huerta et al. Thrombosis Journal 2008 6:10 doi:10.1186/1477-9560-6-10 |
||||||